The use of medicinal plants in disease treatment is on the rise. The extraction and analysis of herbal compounds for their effects on various diseases, including cancer, have garnered significant attention (
1). Curcumin, chemically known as diferuloylmethane, is an active compound found in the rhizome of the turmeric plant (
Curcuma longa) (
2) (
Figure 1). The yellow and golden hue of turmeric is primarily attributed to curcumin, which constitutes approximately 2% to 8% of its compounds, contributing to many of turmeric's properties (
3,
4).
Curcumin was first extracted and purified from turmeric in 1815, with its structure identified as diferuloylmethane in 1910 (
5). It was determined that curcumin is formed through a bond between two chromophore groups of aryl butene-2-anne (feruloy) and a methylene group (
3,
5,
6). Curcumin possesses both phenolic groups and conjugated bonds, rendering it a lipophilic fluorescent substance (
1,
2).
Curcumin exhibits extensive pharmacological activities, including antioxidant, anti-inflammatory, antimicrobial, and anti-cancer properties, despite its low intrinsic toxicity (
2,
6,
7). Additional activities attributed to curcumin include hypolipidemic effects (
8), liver protection (
9), inhibition of lipoxygenase (LOX) (
10) and cyclooxygenase (COX) (
11), protease inhibition (
12), free radical scavenging (
13), inhibition of lipid peroxidation (
14), cholesterol reduction (
15), reduction of platelet aggregation (
16), reduction of cancer cell proliferation (
17), enhancement of food digestion through increased bile flow (
18), and modulation of cytokines and other inflammatory factors (
19,
20).
Currently, it is believed that an imbalance of inflammatory reactants contributes to many chronic diseases (
21,
22). Turmeric, particularly curcumin, has demonstrated a significant anti-inflammatory effect across multiple systems, as evidenced by recent scientific studies. Consequently, turmeric and curcumin are extensively used in the treatment of numerous diseases (
23-
27).